VenatoRx Pharmaceuticals | Antibacterial and Antiviral Drug R&D

World leader in antibacterial & antiviral drug research and development

About Venatorx Pharmaceuticals

Venatorx Pharmaceuticals is a private company that is focused on the discovery and development of novel anti-infectives to treat multi-drug-resistant (MDR) bacterial infections and hard-to-treat viral infections.

ABOUT US

Our Culture

Venatorx Named ‘Best Places to Work’ by Philadelphia Business Journal Four Years in a Row

AWARDS

“This is an all-for-one, one-for-all setting. We have had a lot of successes. We’ve had some setbacks. When we face setbacks, we pick ourselves up, we dust ourselves off. We get back into the game. Our team members take a lot of responsibility for what they do here. There isn’t a problem that our team can’t solve.”

Daniel C. Pevear, Ph.D. – Founder and Senior Vice President, Biology and Grants Development

CAREERS

News & Events

Press Releases

May 16, 2024

Venatorx Pharmaceuticals Announces Changes to Executive Leadership

March 12, 2024

Venatorx Pharmaceuticals Expands Senior Leadership Team

In the News

November 11, 2023

Melinta Therapeutics Partnering with Venatorx Pharmaceuticals on Commercializing Antibiotic

Events

NEWS & EVENTS